Play

Lifestyle factors that influence health include what you eat, how much you exercise and even simply more around, how much mental stimulation you get and how social you are, and these factors do influence your risk of developing dementia. Anja …

How do diet, exercise, and increased cognitive activity reduce the risk of dementia? Elizabeth Tracey reports Read more »

Play

Your vascular system consists of your heart and blood vessels, and its health has a lot to do with whether you will develop dementia as you get older. That’s according to Anja Soldan, a dementia expert at Johns Hopkins. Soldan: …

The health of your heart and blood vessels has a lot to do with whether you’ll develop dementia, Elizabeth Tracey reports Read more »

Play

Avoiding dementia is high on the list in most people’s plan for aging well. Anja Soldan, an Alzheimer’s disease expert at Johns Hopkins, offers a place to start. Soldan: What I always like to say is what’s good for your …

If you’re concerned about your dementia risk you may want to involve your heart, Elizabeth Tracey reports Read more »

Play

Medicare is poised to spend millions of dollars on aducanumab, a just approved drug for Alzheimer’s disease the FDA’s own advisory panel recommended against approving. Caleb Alexander, a member of the panel and an internal medicine expert at Johns Hopkins, …

A confirmatory trial for a new Alzheimer’s disease drug is many years away, Elizabeth Tracey reports Read more »

Play

Is amyloid, a substance that accumulates in the brains of people with Alzheimer’s disease, the cause of the disease or simply a bystander? No one knows, and that’s why an FDA advisory panel voted against approving a new drug to …

Why is a new Alzheimer’s drug so controversial? Elizabeth Tracey reports Read more »

Play

The amyloid hypothesis. That’s the idea that accumulation of a material called amyloid in the brain leads to Alzheimer’s disease. Acceptance of this idea has led the FDA to approve aducanumab, which reduces amyloid, but isn’t known to improve any …

How should drug effectiveness in Alzheimer’s disease be measured? Elizabeth Tracey reports Read more »

Play

Aducanumab or Aduhelm is a newly approved medicine for treating Alzheimer’s disease, with many experts asserting that it should never have gotten FDA approval. Caleb Alexander, an internal medicine expert at Johns Hopkins and a member of the FDA review …

How did Anuhelm, a new drug for Alzheimer’s disease, get approved? Elizabeth Tracey reports Read more »